Evidence map›Paper›PMID 39316199›Full record

ArticleMarine biotechnology (New York, N.Y.)2024

Genome Mining Analysis Uncovers the Previously Unknown Biosynthetic Capacity for Secondary Metabolites in Verrucomicrobia.

Xue Di, Peng Li, Jingxuan Wang, Vincent Nowak, Shuai Zhi, Meiling Jin, Liwei Liu, Shan He

Abstract read
PubMed Publisher
In one paragraph

Article in Marine biotechnology (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xue DiBiopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Peng LiBiopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Jingxuan WangBiopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.
Vincent NowakSchool of Biological Sciences and Centre for Biodiscovery, Victoria University of Wellington, Wellington, 6012, New Zealand.
Shuai ZhiSchool of Public Health, Ningbo University, Ningbo, 315000, Zhejiang, China.
Meiling JinChinese Academy of Sciences (CAS) Key Laboratory of Quantitative Engineering Biology, Shenzhen Institutes of Advanced Technology, Shenzhen Institute of Synthetic Biology, Shenzhen, 518055, Guangdong, China.
Liwei LiuBiopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China. liuliwei@nbu.edu.cn.
Shan HeBiopharmaceutical Research Center, Health Science Center, Ningbo University, Ningbo, 315211, Zhejiang, China.

Funding

National Natural Science Foundation of China 42176101,31600016Ningbo Natural Science Foundation 2021S129Startup Foundation of Ningbo University 422010882, 422110473, 422207513the National 111 Project of China D16013the Ningbo Key Science and Technology Development Program 2021Z046
6 · The paper itself

Abstract

Bacteria of the phylum Verrucomicrobia is widely distributed in diverse ecological environments. Their limited cultivability has greatly caused the significant knowledge gap surrounding their secondary metabolites and their mediating ecological functions. This study delved into the diversity and novelty of secondary metabolite biosynthetic gene clusters (BGCs) of Verrucomicrobia by employing a gene-first approach to investigate 2323 genomes. A total of 7552 BGCs, which encompassed 3744 terpene, 805 polyketide, 773 non-ribosomal peptide gene clusters, and 1933 BGCs of other biosynthetic origins, were identified. They were further classified into 3887 gene cluster families (GCFs) based on biosynthetic gene similarity clustering, of which only six GCFs contained reference biosynthetic gene clusters in the Minimum Information about a Biosynthetic Gene Cluster (MIBiG), indicating the striking novelty of secondary metabolites in Verrucomicrobia. Notably, 37.8% of these gene clusters were harbored by unclassified species of Verrucomicrobia phyla, members of which were highly abundant in soil environments. Furthermore, our comprehensive analysis also revealed Luteolibacter and Methylacidiphilum as the most prolific genera in terms of BGC abundance and diversity, with the discovery of a conservative and new NRPS-PKS BGC in Luteolibacter. This work not only unveiled the biosynthetic potential and genetic diversity of secondary metabolites of Verrucomicrobia but also provided a fresh insight for the exploration of new bioactive compounds.

Indexed as

Genome, BacterialMultigene FamilySecondary MetabolismBacteriaPhylogenyPolyketidesTerpenesPolyketidesTerpenesBiosynthetic Gene ClusterGenome MiningNatural ProductsSecondary MetabolitesVerrucomicrobia

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.